Surgery Doctors in Grosse Pointe Woods, MI Accepting Medicare

4 Surgery doctors found. Showing 1 - 4

Cheryl A Wesen, MD Surgery Medicare: Medicare Enrolled Practice Location: 19229 Mack Ave, Ste 34, Grosse Pointe Woods, MI 48236 Phone: 313-647-3912    Fax: 313-347-3902

Dr. Atbin Doroodchi, MD Surgery Medicare: Medicare Enrolled Practice Location: 19251 Mack Ave Ste 340, Grosse Pointe Woods, MI 48236 Phone: 586-578-9595

Dr. Richard Nazih Berri, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 19229 Mack Ave Ste 23, Grosse Pointe Woods, MI 48236 Phone: 313-647-3252

Dr. Jeffrey Scott Falk, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 19229 Mack Ave, Suite 34, Grosse Pointe Woods, MI 48236 Phone: 313-647-3900    Fax: 313-647-3902

News Archive

Brittle bones does not significantly affect occurrence of bone fractures among older people

Anti-osteoporotic medication is not an effective means for preventing hip fractures among the elderly, concludes a study recently published in the BMJ. According to Professor Teppo Järvinen from the University of Helsinki, who heads the research group, the prevalent assumption that brittle bones cause hip fractures is fundamentally flawed.

Researchers find way to make changes to enzyme-driven assembly line to improve antibiotics

Researchers from North Carolina State University have discovered a way to make pinpoint changes to an enzyme-driven "assembly line" that will enable scientists to improve or change the properties of existing antibiotics as well as create designer compounds.

CytRx granted patent for molecular chaperone amplifier drug candidate

CytRx Corporation, a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced that it has been granted a key patent by the European Patent Office that covers through 2024 the use of its orally available molecular chaperone amplifier drug candidate arimoclomol for the treatment or prevention of neurodegenerative diseases of the central nervous system (CNS).

Research reveals new information about the genetic complexity underpinning schizophrenia

The Icahn School of Medicine at Mount Sinai today announced the publication of two papers in the journal Nature that reveal new information about the genetic complexity underpinning schizophrenia. These collaborative studies represent the largest exome sequencing efforts to date to elucidate this mental illness, and together found that the disorder is likely caused by far more rare genetic mutations than previously suspected.

Reduced activity of transcription factor plays key role in triggering pulmonary fibrosis

To date, the molecular basis of pulmonary fibrosis has been poorly understood. Scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim have now shown that reduced activity of the transcription factor FoxO3 plays a key role in the development of the disease.

Read more Medical News

› Verified 6 days ago